nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ALB—pancreatitis	0.35	1	CbGaD
Imatinib—ORM1—bile—pancreatitis	0.0128	0.0741	CbGeAlD
Imatinib—CA6—exocrine gland—pancreatitis	0.00797	0.0459	CbGeAlD
Imatinib—ABCA3—islet of Langerhans—pancreatitis	0.00765	0.0441	CbGeAlD
Imatinib—DDR1—islet of Langerhans—pancreatitis	0.00706	0.0407	CbGeAlD
Imatinib—CA9—gall bladder—pancreatitis	0.00607	0.035	CbGeAlD
Imatinib—Blepharitis—Hyoscyamine—pancreatitis	0.0053	0.0309	CcSEcCtD
Imatinib—DDR1—pancreas—pancreatitis	0.00496	0.0286	CbGeAlD
Imatinib—PDGFRA—gall bladder—pancreatitis	0.00487	0.0281	CbGeAlD
Imatinib—Haemoglobin decreased—Hyoscyamine—pancreatitis	0.00474	0.0276	CcSEcCtD
Imatinib—Heartburn—Hyoscyamine—pancreatitis	0.00474	0.0276	CcSEcCtD
Imatinib—KIT—exocrine gland—pancreatitis	0.00463	0.0267	CbGeAlD
Imatinib—ABCA3—blood—pancreatitis	0.00437	0.0252	CbGeAlD
Imatinib—PIP4K2C—islet of Langerhans—pancreatitis	0.00436	0.0251	CbGeAlD
Imatinib—DDR1—blood—pancreatitis	0.00404	0.0233	CbGeAlD
Imatinib—Abdominal distension—Propantheline—pancreatitis	0.00402	0.0234	CcSEcCtD
Imatinib—Dysphagia—Propantheline—pancreatitis	0.00399	0.0233	CcSEcCtD
Imatinib—CA9—islet of Langerhans—pancreatitis	0.00398	0.023	CbGeAlD
Imatinib—Petechiae—Hyoscyamine—pancreatitis	0.00396	0.0231	CcSEcCtD
Imatinib—KIT—gall bladder—pancreatitis	0.00389	0.0224	CbGeAlD
Imatinib—PDGFRB—gall bladder—pancreatitis	0.0038	0.0219	CbGeAlD
Imatinib—Erectile dysfunction—Propantheline—pancreatitis	0.00368	0.0214	CcSEcCtD
Imatinib—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.00361	0.021	CcSEcCtD
Imatinib—ORM1—gall bladder—pancreatitis	0.00357	0.0206	CbGeAlD
Imatinib—NQO2—islet of Langerhans—pancreatitis	0.0032	0.0184	CbGeAlD
Imatinib—ALB—gall bladder—pancreatitis	0.00313	0.018	CbGeAlD
Imatinib—Skin exfoliation—Hyoscyamine—pancreatitis	0.00311	0.0181	CcSEcCtD
Imatinib—PIP4K2C—pancreas—pancreatitis	0.00306	0.0177	CbGeAlD
Imatinib—Dry eye—Hyoscyamine—pancreatitis	0.00301	0.0175	CcSEcCtD
Imatinib—Flushing—Propantheline—pancreatitis	0.00297	0.0173	CcSEcCtD
Imatinib—Pulmonary oedema—Hyoscyamine—pancreatitis	0.0029	0.0169	CcSEcCtD
Imatinib—CA2—exocrine gland—pancreatitis	0.00274	0.0158	CbGeAlD
Imatinib—CA7—digestive system—pancreatitis	0.00272	0.0157	CbGeAlD
Imatinib—ABL2—blood—pancreatitis	0.00263	0.0152	CbGeAlD
Imatinib—Eczema—Hyoscyamine—pancreatitis	0.00263	0.0153	CcSEcCtD
Imatinib—Vision blurred—Propantheline—pancreatitis	0.00262	0.0153	CcSEcCtD
Imatinib—Eye pain—Hyoscyamine—pancreatitis	0.00262	0.0153	CcSEcCtD
Imatinib—Atrial fibrillation—Hyoscyamine—pancreatitis	0.0025	0.0146	CcSEcCtD
Imatinib—PDGFRB—islet of Langerhans—pancreatitis	0.00249	0.0144	CbGeAlD
Imatinib—PIP4K2C—blood—pancreatitis	0.00249	0.0144	CbGeAlD
Imatinib—Palpitations—Propantheline—pancreatitis	0.00246	0.0143	CcSEcCtD
Imatinib—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00242	0.0141	CcSEcCtD
Imatinib—Lethargy—Hyoscyamine—pancreatitis	0.00241	0.0141	CcSEcCtD
Imatinib—CA9—digestive system—pancreatitis	0.00239	0.0138	CbGeAlD
Imatinib—Hyponatraemia—Hyoscyamine—pancreatitis	0.00238	0.0138	CcSEcCtD
Imatinib—Dry mouth—Propantheline—pancreatitis	0.00232	0.0135	CcSEcCtD
Imatinib—CA2—gall bladder—pancreatitis	0.00231	0.0133	CbGeAlD
Imatinib—Confusional state—Propantheline—pancreatitis	0.00229	0.0134	CcSEcCtD
Imatinib—Anaphylactic shock—Propantheline—pancreatitis	0.00227	0.0132	CcSEcCtD
Imatinib—Cardiac arrest—Hyoscyamine—pancreatitis	0.00225	0.0131	CcSEcCtD
Imatinib—NQO2—pancreas—pancreatitis	0.00225	0.013	CbGeAlD
Imatinib—ABL1—islet of Langerhans—pancreatitis	0.00222	0.0128	CbGeAlD
Imatinib—Tachycardia—Propantheline—pancreatitis	0.00222	0.0129	CcSEcCtD
Imatinib—LCK—blood—pancreatitis	0.00221	0.0128	CbGeAlD
Imatinib—Dehydration—Hyoscyamine—pancreatitis	0.0022	0.0128	CcSEcCtD
Imatinib—Dry skin—Hyoscyamine—pancreatitis	0.00217	0.0126	CcSEcCtD
Imatinib—Hypokalaemia—Hyoscyamine—pancreatitis	0.00215	0.0126	CcSEcCtD
Imatinib—Abdominal distension—Hyoscyamine—pancreatitis	0.00206	0.012	CcSEcCtD
Imatinib—Insomnia—Propantheline—pancreatitis	0.00205	0.012	CcSEcCtD
Imatinib—Dysphagia—Hyoscyamine—pancreatitis	0.00205	0.0119	CcSEcCtD
Imatinib—Somnolence—Propantheline—pancreatitis	0.00202	0.0118	CcSEcCtD
Imatinib—Angina pectoris—Hyoscyamine—pancreatitis	0.00199	0.0116	CcSEcCtD
Imatinib—Constipation—Propantheline—pancreatitis	0.00194	0.0113	CcSEcCtD
Imatinib—PDGFRA—digestive system—pancreatitis	0.00192	0.011	CbGeAlD
Imatinib—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00188	0.011	CcSEcCtD
Imatinib—Feeling abnormal—Propantheline—pancreatitis	0.00187	0.0109	CcSEcCtD
Imatinib—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00184	0.0108	CcSEcCtD
Imatinib—NQO2—blood—pancreatitis	0.00183	0.0105	CbGeAlD
Imatinib—PDGFRA—blood—pancreatitis	0.00183	0.0105	CbGeAlD
Imatinib—SLC22A2—digestive system—pancreatitis	0.00182	0.0105	CbGeAlD
Imatinib—Depression—Hyoscyamine—pancreatitis	0.00182	0.0106	CcSEcCtD
Imatinib—Urticaria—Propantheline—pancreatitis	0.0018	0.0105	CcSEcCtD
Imatinib—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.0018	0.0105	CcSEcCtD
Imatinib—KIT—pancreas—pancreatitis	0.00179	0.0103	CbGeAlD
Imatinib—Myocardial infarction—Hyoscyamine—pancreatitis	0.00179	0.0104	CcSEcCtD
Imatinib—Conjunctivitis—Hyoscyamine—pancreatitis	0.00177	0.0103	CcSEcCtD
Imatinib—CA12—digestive system—pancreatitis	0.00177	0.0102	CbGeAlD
Imatinib—PDGFRB—pancreas—pancreatitis	0.00175	0.0101	CbGeAlD
Imatinib—Sweating—Hyoscyamine—pancreatitis	0.00175	0.0102	CcSEcCtD
Imatinib—CSF1R—digestive system—pancreatitis	0.00169	0.00972	CbGeAlD
Imatinib—Hypersensitivity—Propantheline—pancreatitis	0.00167	0.00976	CcSEcCtD
Imatinib—CA1—pancreas—pancreatitis	0.00164	0.00946	CbGeAlD
Imatinib—Asthenia—Propantheline—pancreatitis	0.00163	0.0095	CcSEcCtD
Imatinib—CSF1R—blood—pancreatitis	0.00161	0.00926	CbGeAlD
Imatinib—ABL1—pancreas—pancreatitis	0.00156	0.009	CbGeAlD
Imatinib—SLC47A1—digestive system—pancreatitis	0.00154	0.00888	CbGeAlD
Imatinib—KIT—digestive system—pancreatitis	0.00153	0.00883	CbGeAlD
Imatinib—Flushing—Hyoscyamine—pancreatitis	0.00152	0.00885	CcSEcCtD
Imatinib—CA2—islet of Langerhans—pancreatitis	0.00151	0.00872	CbGeAlD
Imatinib—Dizziness—Propantheline—pancreatitis	0.0015	0.00876	CcSEcCtD
Imatinib—PDGFRB—digestive system—pancreatitis	0.0015	0.00862	CbGeAlD
Imatinib—SLC47A1—blood—pancreatitis	0.00147	0.00846	CbGeAlD
Imatinib—Arrhythmia—Hyoscyamine—pancreatitis	0.00146	0.00852	CcSEcCtD
Imatinib—KIT—blood—pancreatitis	0.00146	0.00841	CbGeAlD
Imatinib—Vomiting—Propantheline—pancreatitis	0.00144	0.00842	CcSEcCtD
Imatinib—Mental disorder—Hyoscyamine—pancreatitis	0.00143	0.00836	CcSEcCtD
Imatinib—Rash—Propantheline—pancreatitis	0.00143	0.00835	CcSEcCtD
Imatinib—Dermatitis—Propantheline—pancreatitis	0.00143	0.00834	CcSEcCtD
Imatinib—PDGFRB—blood—pancreatitis	0.00143	0.00822	CbGeAlD
Imatinib—Erythema—Hyoscyamine—pancreatitis	0.00142	0.00831	CcSEcCtD
Imatinib—Headache—Propantheline—pancreatitis	0.00142	0.0083	CcSEcCtD
Imatinib—CA1—digestive system—pancreatitis	0.0014	0.00808	CbGeAlD
Imatinib—Dysgeusia—Hyoscyamine—pancreatitis	0.0014	0.00813	CcSEcCtD
Imatinib—Nausea—Propantheline—pancreatitis	0.00135	0.00787	CcSEcCtD
Imatinib—Vision blurred—Hyoscyamine—pancreatitis	0.00134	0.00783	CcSEcCtD
Imatinib—ORM1—blood—pancreatitis	0.00134	0.00771	CbGeAlD
Imatinib—CA1—blood—pancreatitis	0.00133	0.00769	CbGeAlD
Imatinib—ABL1—digestive system—pancreatitis	0.00133	0.00769	CbGeAlD
Imatinib—Angioedema—Hyoscyamine—pancreatitis	0.0013	0.00759	CcSEcCtD
Imatinib—CYP3A5—islet of Langerhans—pancreatitis	0.0013	0.0075	CbGeAlD
Imatinib—Vertigo—Hyoscyamine—pancreatitis	0.00128	0.00746	CcSEcCtD
Imatinib—Syncope—Hyoscyamine—pancreatitis	0.00128	0.00745	CcSEcCtD
Imatinib—ABL1—blood—pancreatitis	0.00127	0.00732	CbGeAlD
Imatinib—Palpitations—Hyoscyamine—pancreatitis	0.00126	0.00734	CcSEcCtD
Imatinib—Loss of consciousness—Hyoscyamine—pancreatitis	0.00125	0.0073	CcSEcCtD
Imatinib—Convulsion—Hyoscyamine—pancreatitis	0.00123	0.0072	CcSEcCtD
Imatinib—SLC22A1—blood—pancreatitis	0.00122	0.00706	CbGeAlD
Imatinib—Chest pain—Hyoscyamine—pancreatitis	0.00121	0.00707	CcSEcCtD
Imatinib—Anxiety—Hyoscyamine—pancreatitis	0.00121	0.00705	CcSEcCtD
Imatinib—Dry mouth—Hyoscyamine—pancreatitis	0.00119	0.00692	CcSEcCtD
Imatinib—Confusional state—Hyoscyamine—pancreatitis	0.00117	0.00683	CcSEcCtD
Imatinib—Oedema—Hyoscyamine—pancreatitis	0.00116	0.00678	CcSEcCtD
Imatinib—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00116	0.00678	CcSEcCtD
Imatinib—Shock—Hyoscyamine—pancreatitis	0.00114	0.00667	CcSEcCtD
Imatinib—Tachycardia—Hyoscyamine—pancreatitis	0.00114	0.00662	CcSEcCtD
Imatinib—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00112	0.00655	CcSEcCtD
Imatinib—Hypotension—Hyoscyamine—pancreatitis	0.00109	0.00633	CcSEcCtD
Imatinib—CA2—pancreas—pancreatitis	0.00106	0.00613	CbGeAlD
Imatinib—Insomnia—Hyoscyamine—pancreatitis	0.00105	0.00613	CcSEcCtD
Imatinib—Dyspnoea—Hyoscyamine—pancreatitis	0.00104	0.00604	CcSEcCtD
Imatinib—Somnolence—Hyoscyamine—pancreatitis	0.00103	0.00603	CcSEcCtD
Imatinib—Dyspepsia—Hyoscyamine—pancreatitis	0.00102	0.00597	CcSEcCtD
Imatinib—Fatigue—Hyoscyamine—pancreatitis	0.001	0.00584	CcSEcCtD
Imatinib—Pain—Hyoscyamine—pancreatitis	0.000995	0.0058	CcSEcCtD
Imatinib—Constipation—Hyoscyamine—pancreatitis	0.000995	0.0058	CcSEcCtD
Imatinib—CYP2C19—digestive system—pancreatitis	0.000991	0.00571	CbGeAlD
Imatinib—Feeling abnormal—Hyoscyamine—pancreatitis	0.000958	0.00559	CcSEcCtD
Imatinib—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000951	0.00554	CcSEcCtD
Imatinib—CYP2C19—blood—pancreatitis	0.000944	0.00544	CbGeAlD
Imatinib—Urticaria—Hyoscyamine—pancreatitis	0.000924	0.00538	CcSEcCtD
Imatinib—Abdominal pain—Hyoscyamine—pancreatitis	0.000919	0.00536	CcSEcCtD
Imatinib—Body temperature increased—Hyoscyamine—pancreatitis	0.000919	0.00536	CcSEcCtD
Imatinib—CYP3A5—pancreas—pancreatitis	0.000914	0.00527	CbGeAlD
Imatinib—CA2—digestive system—pancreatitis	0.000908	0.00523	CbGeAlD
Imatinib—CA2—blood—pancreatitis	0.000865	0.00499	CbGeAlD
Imatinib—Hypersensitivity—Hyoscyamine—pancreatitis	0.000857	0.00499	CcSEcCtD
Imatinib—Asthenia—Hyoscyamine—pancreatitis	0.000834	0.00486	CcSEcCtD
Imatinib—Pruritus—Hyoscyamine—pancreatitis	0.000823	0.0048	CcSEcCtD
Imatinib—CYP1A2—digestive system—pancreatitis	0.000809	0.00467	CbGeAlD
Imatinib—ABCG2—blood—pancreatitis	0.000801	0.00462	CbGeAlD
Imatinib—Diarrhoea—Hyoscyamine—pancreatitis	0.000796	0.00464	CcSEcCtD
Imatinib—CYP3A5—digestive system—pancreatitis	0.000781	0.0045	CbGeAlD
Imatinib—CYP1A2—blood—pancreatitis	0.000771	0.00444	CbGeAlD
Imatinib—Dizziness—Hyoscyamine—pancreatitis	0.000769	0.00448	CcSEcCtD
Imatinib—CYP2C9—digestive system—pancreatitis	0.000768	0.00443	CbGeAlD
Imatinib—CYP3A5—blood—pancreatitis	0.000744	0.00429	CbGeAlD
Imatinib—Vomiting—Hyoscyamine—pancreatitis	0.000739	0.00431	CcSEcCtD
Imatinib—Rash—Hyoscyamine—pancreatitis	0.000733	0.00427	CcSEcCtD
Imatinib—Dermatitis—Hyoscyamine—pancreatitis	0.000733	0.00427	CcSEcCtD
Imatinib—CYP2C9—blood—pancreatitis	0.000732	0.00422	CbGeAlD
Imatinib—Headache—Hyoscyamine—pancreatitis	0.000729	0.00425	CcSEcCtD
Imatinib—PTGS1—digestive system—pancreatitis	0.000701	0.00404	CbGeAlD
Imatinib—Nausea—Hyoscyamine—pancreatitis	0.000691	0.00403	CcSEcCtD
Imatinib—ABCB1—islet of Langerhans—pancreatitis	0.000691	0.00398	CbGeAlD
Imatinib—PTGS1—blood—pancreatitis	0.000668	0.00385	CbGeAlD
Imatinib—CYP3A4—digestive system—pancreatitis	0.000586	0.00338	CbGeAlD
Imatinib—CYP2D6—digestive system—pancreatitis	0.000576	0.00332	CbGeAlD
Imatinib—CYP3A4—blood—pancreatitis	0.000558	0.00322	CbGeAlD
Imatinib—CYP2D6—blood—pancreatitis	0.000549	0.00317	CbGeAlD
Imatinib—ABCB1—pancreas—pancreatitis	0.000486	0.0028	CbGeAlD
Imatinib—ABCB1—digestive system—pancreatitis	0.000415	0.00239	CbGeAlD
Imatinib—ABCB1—blood—pancreatitis	0.000395	0.00228	CbGeAlD
Imatinib—KIT—Adaptive Immune System—HRAS—pancreatitis	2.01e-05	6.59e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—ICAM1—pancreatitis	2.01e-05	6.59e-05	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—pancreatitis	2.01e-05	6.57e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL1B—pancreatitis	2e-05	6.54e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ALDH2—pancreatitis	1.99e-05	6.51e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—HRAS—pancreatitis	1.98e-05	6.5e-05	CbGpPWpGaD
Imatinib—KIT—Disease—PTGS2—pancreatitis	1.98e-05	6.49e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—HRAS—pancreatitis	1.97e-05	6.46e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH1B—pancreatitis	1.97e-05	6.46e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PLA2G1B—pancreatitis	1.97e-05	6.46e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MDM2—pancreatitis	1.96e-05	6.43e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NRAS—pancreatitis	1.96e-05	6.42e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SPP1—pancreatitis	1.95e-05	6.39e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—A2M—pancreatitis	1.95e-05	6.39e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—MDM2—pancreatitis	1.94e-05	6.37e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.94e-05	6.35e-05	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—HRAS—pancreatitis	1.93e-05	6.34e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PRSS1—pancreatitis	1.92e-05	6.29e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—LEP—pancreatitis	1.92e-05	6.28e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—LPL—pancreatitis	1.91e-05	6.27e-05	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HRAS—pancreatitis	1.91e-05	6.24e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—A2M—pancreatitis	1.9e-05	6.23e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—pancreatitis	1.9e-05	6.22e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—LPL—pancreatitis	1.9e-05	6.22e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—MDM2—pancreatitis	1.9e-05	6.22e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—LPL—pancreatitis	1.89e-05	6.21e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL1B—pancreatitis	1.89e-05	6.19e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—pancreatitis	1.89e-05	6.19e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NRAS—pancreatitis	1.88e-05	6.17e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—KRAS—pancreatitis	1.87e-05	6.14e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—pancreatitis	1.87e-05	6.14e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PDGFA—pancreatitis	1.86e-05	6.09e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PLA2G1B—pancreatitis	1.86e-05	6.08e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2A—pancreatitis	1.86e-05	6.08e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.86e-05	6.08e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—MDM2—pancreatitis	1.85e-05	6.06e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PLA2G1B—pancreatitis	1.84e-05	6.03e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—LPL—pancreatitis	1.84e-05	6.03e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CXCL8—pancreatitis	1.84e-05	6.01e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PRSS3—pancreatitis	1.82e-05	5.96e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PNLIP—pancreatitis	1.82e-05	5.96e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—A2M—pancreatitis	1.79e-05	5.88e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—HRAS—pancreatitis	1.79e-05	5.86e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALDH2—pancreatitis	1.78e-05	5.84e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—A2M—pancreatitis	1.78e-05	5.82e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—LPL—pancreatitis	1.77e-05	5.79e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CASP3—pancreatitis	1.76e-05	5.76e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—MDM2—pancreatitis	1.75e-05	5.74e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GCG—pancreatitis	1.75e-05	5.73e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—HRAS—pancreatitis	1.74e-05	5.71e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALDH2—pancreatitis	1.74e-05	5.7e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.74e-05	5.7e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—INS—pancreatitis	1.73e-05	5.66e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—LEP—pancreatitis	1.73e-05	5.65e-05	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HRAS—pancreatitis	1.72e-05	5.62e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—pancreatitis	1.71e-05	5.61e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—pancreatitis	1.7e-05	5.58e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL2—pancreatitis	1.7e-05	5.57e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL5—pancreatitis	1.69e-05	5.54e-05	CbGpPWpGaD
Imatinib—LCK—Disease—INS—pancreatitis	1.69e-05	5.54e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—pancreatitis	1.69e-05	5.53e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—KRAS—pancreatitis	1.69e-05	5.53e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—NRAS—pancreatitis	1.67e-05	5.47e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—pancreatitis	1.67e-05	5.46e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—pancreatitis	1.66e-05	5.43e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LPL—pancreatitis	1.65e-05	5.41e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALDH2—pancreatitis	1.64e-05	5.37e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—INS—pancreatitis	1.64e-05	5.36e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—XDH—pancreatitis	1.63e-05	5.35e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALDH2—pancreatitis	1.63e-05	5.33e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—KRAS—pancreatitis	1.62e-05	5.31e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL2—pancreatitis	1.61e-05	5.28e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—HRAS—pancreatitis	1.59e-05	5.22e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.58e-05	5.19e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NRAS—pancreatitis	1.58e-05	5.18e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PLA2G1B—pancreatitis	1.57e-05	5.15e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SPP1—pancreatitis	1.56e-05	5.13e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.56e-05	5.12e-05	CbGpPWpGaD
Imatinib—KIT—Disease—NRAS—pancreatitis	1.54e-05	5.05e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.52e-05	4.99e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—MDM2—pancreatitis	1.52e-05	4.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH1B—pancreatitis	1.52e-05	4.99e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—A2M—pancreatitis	1.52e-05	4.98e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GCG—pancreatitis	1.51e-05	4.93e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—pancreatitis	1.49e-05	4.88e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—INS—pancreatitis	1.47e-05	4.83e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NRAS—pancreatitis	1.47e-05	4.82e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NRAS—pancreatitis	1.46e-05	4.78e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.45e-05	4.75e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL2—pancreatitis	1.45e-05	4.75e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MDM2—pancreatitis	1.44e-05	4.71e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—KRAS—pancreatitis	1.44e-05	4.71e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—HRAS—pancreatitis	1.43e-05	4.7e-05	CbGpPWpGaD
Imatinib—KIT—Disease—TGFB1—pancreatitis	1.43e-05	4.69e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.43e-05	4.67e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NRAS—pancreatitis	1.42e-05	4.66e-05	CbGpPWpGaD
Imatinib—LCK—Disease—MDM2—pancreatitis	1.41e-05	4.61e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PPARG—pancreatitis	1.4e-05	4.58e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALDH2—pancreatitis	1.39e-05	4.55e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—NRAS—pancreatitis	1.39e-05	4.54e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PPARG—pancreatitis	1.39e-05	4.54e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LEP—pancreatitis	1.38e-05	4.54e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARG—pancreatitis	1.38e-05	4.53e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HRAS—pancreatitis	1.38e-05	4.51e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—pancreatitis	1.37e-05	4.5e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—LPL—pancreatitis	1.37e-05	4.49e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—INS—pancreatitis	1.37e-05	4.49e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—pancreatitis	1.37e-05	4.48e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.37e-05	4.48e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—pancreatitis	1.37e-05	4.47e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MDM2—pancreatitis	1.36e-05	4.46e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—KRAS—pancreatitis	1.36e-05	4.45e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—INS—pancreatitis	1.36e-05	4.45e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—INS—pancreatitis	1.36e-05	4.45e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—pancreatitis	1.36e-05	4.44e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—pancreatitis	1.36e-05	4.44e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.35e-05	4.44e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GCG—pancreatitis	1.35e-05	4.43e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL8—pancreatitis	1.34e-05	4.41e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARG—pancreatitis	1.34e-05	4.4e-05	CbGpPWpGaD
Imatinib—KIT—Disease—KRAS—pancreatitis	1.33e-05	4.34e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GCG—pancreatitis	1.32e-05	4.32e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—INS—pancreatitis	1.32e-05	4.32e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NRAS—pancreatitis	1.31e-05	4.31e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NRAS—pancreatitis	1.3e-05	4.27e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARG—pancreatitis	1.29e-05	4.22e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CASP3—pancreatitis	1.29e-05	4.22e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL8—pancreatitis	1.27e-05	4.17e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KRAS—pancreatitis	1.27e-05	4.15e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—INS—pancreatitis	1.26e-05	4.14e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—pancreatitis	1.26e-05	4.12e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—KRAS—pancreatitis	1.26e-05	4.11e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.25e-05	4.09e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—pancreatitis	1.25e-05	4.08e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—pancreatitis	1.24e-05	4.08e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GCG—pancreatitis	1.24e-05	4.07e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GCG—pancreatitis	1.23e-05	4.04e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MDM2—pancreatitis	1.23e-05	4.02e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—KRAS—pancreatitis	1.22e-05	4.01e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—pancreatitis	1.22e-05	4e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—HRAS—pancreatitis	1.22e-05	4e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CASP3—pancreatitis	1.22e-05	3.99e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.22e-05	3.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.21e-05	3.98e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—pancreatitis	1.21e-05	3.96e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—pancreatitis	1.21e-05	3.96e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—KRAS—pancreatitis	1.19e-05	3.91e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—INS—pancreatitis	1.18e-05	3.88e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—LPL—pancreatitis	1.18e-05	3.87e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—A2M—pancreatitis	1.17e-05	3.84e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—pancreatitis	1.17e-05	3.83e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL2—pancreatitis	1.16e-05	3.81e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—pancreatitis	1.16e-05	3.8e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HRAS—pancreatitis	1.16e-05	3.79e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL8—pancreatitis	1.15e-05	3.76e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—NRAS—pancreatitis	1.14e-05	3.74e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—KRAS—pancreatitis	1.13e-05	3.71e-05	CbGpPWpGaD
Imatinib—KIT—Disease—HRAS—pancreatitis	1.13e-05	3.69e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—KRAS—pancreatitis	1.12e-05	3.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—pancreatitis	1.11e-05	3.62e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—pancreatitis	1.1e-05	3.6e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CASP3—pancreatitis	1.1e-05	3.6e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—pancreatitis	1.09e-05	3.57e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—pancreatitis	1.09e-05	3.57e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NRAS—pancreatitis	1.08e-05	3.54e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—pancreatitis	1.08e-05	3.53e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HRAS—pancreatitis	1.08e-05	3.53e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALDH2—pancreatitis	1.07e-05	3.51e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HRAS—pancreatitis	1.07e-05	3.5e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.07e-05	3.49e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—LPL—pancreatitis	1.06e-05	3.47e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—pancreatitis	1.06e-05	3.46e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NRAS—pancreatitis	1.05e-05	3.45e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GCG—pancreatitis	1.05e-05	3.45e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HRAS—pancreatitis	1.04e-05	3.41e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—LPL—pancreatitis	1.03e-05	3.39e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—pancreatitis	1.03e-05	3.38e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NRAS—pancreatitis	1.02e-05	3.35e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—pancreatitis	1.02e-05	3.35e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—HRAS—pancreatitis	1.01e-05	3.32e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—pancreatitis	1.01e-05	3.32e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—pancreatitis	1e-05	3.28e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—pancreatitis	1e-05	3.28e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—pancreatitis	9.96e-06	3.26e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MDM2—pancreatitis	9.84e-06	3.23e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—KRAS—pancreatitis	9.83e-06	3.22e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—INS—pancreatitis	9.82e-06	3.22e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—pancreatitis	9.8e-06	3.21e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—LPL—pancreatitis	9.75e-06	3.2e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—pancreatitis	9.71e-06	3.18e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—LPL—pancreatitis	9.67e-06	3.17e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HRAS—pancreatitis	9.61e-06	3.15e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—HRAS—pancreatitis	9.52e-06	3.12e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—pancreatitis	9.49e-06	3.11e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—KRAS—pancreatitis	9.29e-06	3.04e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL8—pancreatitis	9.2e-06	3.02e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NRAS—pancreatitis	9.2e-06	3.01e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—pancreatitis	9.2e-06	3.01e-05	CbGpPWpGaD
Imatinib—LCK—Disease—KRAS—pancreatitis	9.07e-06	2.97e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—pancreatitis	9e-06	2.95e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CASP3—pancreatitis	8.81e-06	2.89e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KRAS—pancreatitis	8.79e-06	2.88e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—pancreatitis	8.62e-06	2.83e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—pancreatitis	8.55e-06	2.8e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—INS—pancreatitis	8.46e-06	2.77e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—HRAS—pancreatitis	8.35e-06	2.74e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—LPL—pancreatitis	8.26e-06	2.71e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCG—pancreatitis	8.13e-06	2.66e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—pancreatitis	8e-06	2.62e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KRAS—pancreatitis	7.92e-06	2.59e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HRAS—pancreatitis	7.89e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—pancreatitis	7.88e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—pancreatitis	7.74e-06	2.54e-05	CbGpPWpGaD
Imatinib—LCK—Disease—HRAS—pancreatitis	7.71e-06	2.53e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—INS—pancreatitis	7.59e-06	2.49e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—pancreatitis	7.56e-06	2.48e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—pancreatitis	7.55e-06	2.48e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HRAS—pancreatitis	7.47e-06	2.45e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—INS—pancreatitis	7.41e-06	2.43e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NRAS—pancreatitis	7.38e-06	2.42e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—pancreatitis	7.38e-06	2.42e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—pancreatitis	7.15e-06	2.34e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—pancreatitis	7.12e-06	2.33e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—pancreatitis	7.06e-06	2.31e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—INS—pancreatitis	6.98e-06	2.29e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—pancreatitis	6.96e-06	2.28e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—INS—pancreatitis	6.92e-06	2.27e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—pancreatitis	6.86e-06	2.25e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—pancreatitis	6.79e-06	2.23e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—pancreatitis	6.78e-06	2.22e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HRAS—pancreatitis	6.73e-06	2.21e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—pancreatitis	6.44e-06	2.11e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—pancreatitis	6.4e-06	2.1e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LPL—pancreatitis	6.38e-06	2.09e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KRAS—pancreatitis	6.35e-06	2.08e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—pancreatitis	6.35e-06	2.08e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—pancreatitis	6.09e-06	2e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—pancreatitis	6.03e-06	1.98e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—pancreatitis	5.94e-06	1.95e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—INS—pancreatitis	5.92e-06	1.94e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—pancreatitis	5.6e-06	1.84e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—pancreatitis	5.55e-06	1.82e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—pancreatitis	5.42e-06	1.78e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HRAS—pancreatitis	5.4e-06	1.77e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—pancreatitis	5.17e-06	1.69e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—pancreatitis	4.74e-06	1.55e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—pancreatitis	4.66e-06	1.53e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—INS—pancreatitis	4.57e-06	1.5e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—pancreatitis	4.19e-06	1.37e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—pancreatitis	3.66e-06	1.2e-05	CbGpPWpGaD
